Jessica B. Flechtner

960 total citations
33 papers, 692 citations indexed

About

Jessica B. Flechtner is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Jessica B. Flechtner has authored 33 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 14 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Jessica B. Flechtner's work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Herpesvirus Infections and Treatments (8 papers). Jessica B. Flechtner is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Herpesvirus Infections and Treatments (8 papers). Jessica B. Flechtner collaborates with scholars based in United States and Netherlands. Jessica B. Flechtner's co-authors include Todd M. Gierahn, Darren E. Higgins, Richard Malley, Paulo Gouveia, Kristin Moffitt, Mark R. Alderson, Ying‐Jie Lu, Deborah Long, Mojca Škoberne and David I. Bernstein and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Jessica B. Flechtner

31 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica B. Flechtner United States 15 456 289 175 103 66 33 692
Robin M. Kaufhold United States 11 418 0.9× 159 0.6× 68 0.4× 94 0.9× 109 1.7× 18 626
Dianne J. Marais South Africa 22 776 1.7× 112 0.4× 158 0.9× 55 0.5× 55 0.8× 31 934
Eva-Liz Johansson Sweden 8 243 0.5× 461 1.6× 107 0.6× 145 1.4× 97 1.5× 9 818
L A Borenstein United States 15 422 0.9× 246 0.9× 223 1.3× 120 1.2× 74 1.1× 20 806
Grégory Catteau Belgium 12 766 1.7× 184 0.6× 69 0.4× 48 0.5× 52 0.8× 15 865
Kathleen R. Lottenbach United States 13 598 1.3× 325 1.1× 123 0.7× 145 1.4× 38 0.6× 17 905
Brigitte Colau Netherlands 11 776 1.7× 252 0.9× 125 0.7× 278 2.7× 24 0.4× 16 1.0k
Cecilia Svanholm Sweden 11 129 0.3× 379 1.3× 211 1.2× 145 1.4× 79 1.2× 11 589
S. Ghim United States 11 669 1.5× 343 1.2× 78 0.4× 125 1.2× 68 1.0× 18 879
Bhawna Poonia United States 20 392 0.9× 420 1.5× 56 0.3× 105 1.0× 282 4.3× 50 962

Countries citing papers authored by Jessica B. Flechtner

Since Specialization
Citations

This map shows the geographic impact of Jessica B. Flechtner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica B. Flechtner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica B. Flechtner more than expected).

Fields of papers citing papers by Jessica B. Flechtner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica B. Flechtner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica B. Flechtner. The network helps show where Jessica B. Flechtner may publish in the future.

Co-authorship network of co-authors of Jessica B. Flechtner

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica B. Flechtner. A scholar is included among the top collaborators of Jessica B. Flechtner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica B. Flechtner. Jessica B. Flechtner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gillison, Maura L., Mark M. Awad, Przemyslaw Twardowski, et al.. (2021). 485 Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors. SHILAP Revista de lepidopterología. A515–A515. 1 indexed citations
3.
Gillison, Maura L., Mark M. Awad, Przemyslaw Twardowski, et al.. (2021). Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 2613–2613. 14 indexed citations
4.
Bernstein, David I., Jessica B. Flechtner, Lisa K. McNeil, et al.. (2019). Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease. Vaccine. 37(26). 3443–3450. 27 indexed citations
5.
Twardowski, P., Melissa L. Johnson, Mark N. Stein, et al.. (2019). A phase I trial of GEN-009, a neoantigen vaccine using ATLAS™, an autologous immune assay, to identify immunogenic and inhibitory tumour mutations. Annals of Oncology. 30. v479–v479. 2 indexed citations
6.
Cohen, Roger B., Melissa L. Johnson, Przemyslaw Twardowski, et al.. (2019). A phase 1/2a study of GEN-009, a neoantigen vaccine based on autologous peptide immune responses.. Journal of Clinical Oncology. 37(15_suppl). 2611–2611. 5 indexed citations
7.
8.
Kaufmann, Johanna K., et al.. (2018). Improving Cancer Immunotherapies through Empirical Neoantigen Selection. Trends in cancer. 4(2). 97–100. 11 indexed citations
9.
Kaufmann, Johanna K., Biao Liu, Ning Wu, et al.. (2017). Systematic analysis of T cell responses specific to the Epstein-Barr virus proteome using ATLAS™. The Journal of Immunology. 198(Supplement_1). 78.42–78.42. 1 indexed citations
10.
Flechtner, Jessica B., et al.. (2016). Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial. Vaccine. 34(44). 5314–5320. 21 indexed citations
11.
Zheng, Xiaojing, Catherine M. O’Connell, Harold C. Wiesenfeld, et al.. (2016). Identification ofChlamydia trachomatisAntigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection. The Journal of Infectious Diseases. 214(12). 1884–1892. 41 indexed citations
12.
Kaufmann, Johanna K. & Jessica B. Flechtner. (2016). Evolution of rational vaccine designs for genital herpes immunotherapy. Current Opinion in Virology. 17. 80–86. 8 indexed citations
13.
Blevins, Tamara P., Lynda A. Morrison, Mojca Škoberne, et al.. (2016). Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples. Vaccine. 34(33). 3901–3906. 6 indexed citations
14.
Picard, Michele D., Jean-Luc Bodmer, Todd M. Gierahn, et al.. (2015). Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile. Clinical and Vaccine Immunology. 22(11). 1206–1218. 22 indexed citations
15.
16.
Moffitt, Kristin, Mojca Škoberne, Angela Howard, et al.. (2014). Toll-Like Receptor 2-Dependent Protection against Pneumococcal Carriage by Immunization with Lipidated Pneumococcal Proteins. Infection and Immunity. 82(5). 2079–2086. 33 indexed citations
17.
Flechtner, Jessica B., et al.. (2013). Proteins as T cell antigens: Methods for high-throughput identification. Vaccine. 31(37). 3805–3810. 19 indexed citations
18.
19.
Li, Yuan, Todd M. Gierahn, Claudette M. Thompson, et al.. (2012). Distinct Effects on Diversifying Selection by Two Mechanisms of Immunity against Streptococcus pneumoniae. PLoS Pathogens. 8(11). e1002989–e1002989. 38 indexed citations
20.
Moffitt, Kristin, Todd M. Gierahn, Ying‐Jie Lu, et al.. (2011). TH17-Based Vaccine Design for Prevention of Streptococcus pneumoniae Colonization. Cell Host & Microbe. 9(2). 158–165. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robin M. Kaufhold Breakdown of academic impact, for papers by Dianne J. Marais Breakdown of academic impact, for papers by Eva-Liz Johansson Breakdown of academic impact, for papers by L A Borenstein Breakdown of academic impact, for papers by Grégory Catteau Breakdown of academic impact, for papers by Kathleen R. Lottenbach Breakdown of academic impact, for papers by Brigitte Colau Breakdown of academic impact, for papers by Cecilia Svanholm Breakdown of academic impact, for papers by S. Ghim Breakdown of academic impact, for papers by Bhawna Poonia
Rankless by CCL
2026